Hatteras Venture Partners — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation.
AI & Machine LearningDigital HealthHealthtechBranford, US
Joshua Ransom(Executive Officer)David Levin(Chief Executive Officer)inJosh Brown(Chief Technology Officer)inScott Caflisch(Chief Information Security Officer)inJeff Graham(Chief Data Officer)inJennifer Stacey(Chief Operating Officer)in
Board seatJohn Crumpler· per SEC Form D
Co-investorsConnecticut InnovationsExcelerate Health VenturesMartin Ventures
Wildflower Health offers a modular suite of software and services for women's health, combining a digital patient engagement app, a national network of human health advocates and specialists, and value-based care payment model support.
Digital HealthFemTechHealthtechSan Francisco, US
Leah Sparks(CEO & Founder)Kim Russell(Chief Financial Officer of Issuer)
BoardDan Galles(Director of Issuer)inEzra Mehlman(Director of Issuer)Ralph Sabin(Director of Issuer)in
Board seatJohn Crumpler· per SEC Form D
Co-investorsAllumia VenturesEcho Health VenturesHealthtech Capital
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane Hegarty(Executive Officer)Shane V. Hegarty(Chief Scientific Officer & Co-Founder)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)Tiasha Shafiq(Chief of Staff)
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Iaso Ventures+7 more
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.
Deep TechHealthtechMedical DevicesRoseville, US
Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)
BoardKirk Nielsen(Director)in
Co-investorsTreo Ventures, LlcVensana Capital
Synaptrix develops NOVABLOC, a non-opioid neuromodulation therapy that uses electrical stimulation to provide targeted, long-lasting postoperative pain relief.
BiotechDigital HealthMedical DevicesAlpharetta, US
Shyamy Sastry(Executive Officer, Director)
BoardDoug Reed(Director)Robert Crutchfield(Executive Officer, Director)Anita Watkins(Director)Kurt Jacobus(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.